Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Weight loss medication stories

May 3, 2026

GLP-1 Drugs Taken Around Pregnancy Show No Increased Risk of Birth Defects in New Study

University of St Andrews study published in American Journal of Obstetrics suggests weight-loss drugs like Ozempic taken around pregnancy do not raise the risk of major birth defects.

May 3, 2026·1 source
00

Top claims

  • ▪The University of St Andrews researchers describe their findings on GLP-1 drugs and birth defects as reassuring for women who may have been exposed during pregnancy
  • ▪The University of St Andrews study on GLP-1 receptor agonists during pregnancy was published in the American Journal of Obstetrics and Gynaecology
  • ▪The University of St Andrews study on GLP-1 receptor agonists covered a period of 20 years

Subtopics

GLP-1 drugs1GLP-1 medications1Lifestyle, Wellness and Nutrition1Maternal health1Pregnancy health1Reproductive Health1

Related timelines

Congress

108 stories

Payments

118 stories

Russia-Ukraine war

136 stories

Trump administration

116 stories

US health policy & drug pricing

123 stories